{"id":"NCT03620162","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ With Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-10-18","primaryCompletion":"2020-12-14","completion":"2020-12-14","firstPosted":"2018-08-08","resultsPosted":"2021-08-23","lastUpdate":"2023-01-17"},"enrollment":900,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Infections"],"interventions":[{"type":"BIOLOGICAL","name":"Prevnar 13™","otherNames":[]},{"type":"BIOLOGICAL","name":"V114","otherNames":["VAXNEUVANCE™"]},{"type":"BIOLOGICAL","name":"RotaTeq™","otherNames":["V260; trade names of the concomitant vaccines may vary depending on where clinical supplies are sourced."]},{"type":"BIOLOGICAL","name":"Pentacel™","otherNames":["Trade names of the concomitant vaccines may vary depending on where clinical supplies are sourced."]},{"type":"BIOLOGICAL","name":"RECOMBIVAX HB™","otherNames":["V232, HEPTAVAX™-II, HBVAXPRO; trade names of the concomitant vaccines may vary depending on where clinical supplies are sourced."]},{"type":"BIOLOGICAL","name":"HIBERIX™","otherNames":["Trade names of the concomitant vaccines may vary depending on where clinical supplies are sourced."]},{"type":"BIOLOGICAL","name":"M-M-R™ II","otherNames":["V205C; trade names of the concomitant vaccines may vary depending on where clinical supplies are sourced."]},{"type":"BIOLOGICAL","name":"VARIVAX™","otherNames":["V210; trade names of the concomitant vaccines may vary depending on where clinical supplies are sourced."]}],"arms":[{"label":"Group 1: Prevnar 13™-Prevnar 13™-Prevnar 13™-Prevnar 13™","type":"ACTIVE_COMPARATOR"},{"label":"Group 2: Prevnar 13™-Prevnar 13™-Prevnar 13™-V114","type":"EXPERIMENTAL"},{"label":"Group 3: Prevnar 13™-Prevnar 13™-V114-V114","type":"EXPERIMENTAL"},{"label":"Group 4: Prevnar 13™-V114-V114-V114","type":"EXPERIMENTAL"},{"label":"Group 5: V114-V114-V114-V114","type":"EXPERIMENTAL"}],"summary":"The goal of this study is to evaluate the safety, tolerability, and immunogenicity of the Pneumococcal Conjugate Vaccines (PCVs) V114 and Prevnar 13™ in healthy infants switched from Prevnar 13™ to V114 during the four-dose PCV immunization schedule.","primaryOutcome":{"measure":"Percentage of Participants With a Solicited Injection-site Adverse Event (AE)","timeFrame":"Up to ~14 days after each vaccination","effectByArm":[{"arm":"Group 1: Prevnar 13™-Prevnar 13™-Prevnar 13™-Prevnar 13™","deltaMin":47.5,"sd":null},{"arm":"Group 2: Prevnar 13™-Prevnar 13™-Prevnar 13™-V114","deltaMin":37.6,"sd":null},{"arm":"Group 3: Prevnar 13™-Prevnar 13™-V114-V114","deltaMin":38.8,"sd":null},{"arm":"Group 4: Prevnar 13™-V114-V114-V114","deltaMin":43,"sd":null},{"arm":"Group 5: V114-V114-V114-V114","deltaMin":44.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG004","p":"= 0.525"},{"comp":"OG000 vs OG003","p":"= 0.396"},{"comp":"OG000 vs OG002","p":"= 0.097"},{"comp":"OG000 vs OG001","p":"= 0.057"},{"comp":"OG000 vs OG004","p":"= 0.085"},{"comp":"OG000 vs OG003","p":"= 0.050"},{"comp":"OG000 vs OG002","p":"= 0.183"},{"comp":"OG000 vs OG001","p":"= 0.074"},{"comp":"OG000 vs OG004","p":"= 0.525"},{"comp":"OG000 vs OG003","p":"= 0.915"},{"comp":"OG000 vs OG002","p":"= 0.714"},{"comp":"OG000 vs OG001","p":"= 0.926"},{"comp":"OG000 vs OG004","p":"> 0.999"},{"comp":"OG000 vs OG003","p":"= 0.609"},{"comp":"OG000 vs OG002","p":"= 0.688"},{"comp":"OG000 vs OG001","p":"= 0.336"}]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":19},"locations":{"siteCount":34,"countries":["United States","Puerto Rico","Thailand","Turkey (Türkiye)"]},"refs":{"pmids":["36522265"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":179},"commonTop":["Irritability","Somnolence","Injection site pain","Injection site erythema","Decreased appetite"]}}